MarketPeel
Insider Trading Intelligence
MC

Michael Carulli

PMVP
CHIEF FINANCIAL OFFICER · PMV PHARMACEUTICALS, INC. · CIK 0002006668
FILING MIX · LIFETIME55%/45%
BUYS
6
SELLS
5
TOTAL VALUE
$34.4K
COMPANIES
1
ACTIVE SINCE
Jan 2024
HOLDINGS NOW
240,000
AVG SELL PX
$1.11
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Michael Carulli, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%+12.86%+0.85%+12.01%+12.01%
14d2+50.00%+12.67%+1.93%+10.74%+10.74%
30d2+50.00%+16.96%+3.60%+13.36%+13.36%
60d2+0.00%+24.61%+6.38%+18.23%+18.23%
90d2+0.00%+22.03%+8.26%+13.77%+13.77%
180d2+50.00%-1.51%+6.56%-8.07%-8.07%
1y2+50.00%+4.54%+20.32%-15.78%-15.78%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PMVP · 240,000 shares · as of Mar 5, 2026
066,250132,500198,750265,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 6 buys / 5 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
240,000240,000Mar 5, 2026Mar 9, 2026View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
28,249$1.06$30.1K60,146Jul 1, 2025Jul 3, 2025View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
265,000265,000Mar 3, 2025Mar 5, 2025View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,891$1.50$4.3K88,395Sep 11, 2024Sep 12, 2024View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
75,00075,000Aug 13, 2024Oct 3, 2024View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
75,00075,000Aug 13, 2024Oct 3, 2024View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
27,2000Aug 13, 2024Oct 3, 2024View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,80540,805Aug 13, 2024Oct 3, 2024View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
13,6050Aug 13, 2024Oct 3, 2024View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
204,630204,630Jan 18, 2024Jan 22, 2024View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
82,22091,286Jan 18, 2024Jan 22, 2024View →
Other insiders · PMVP
Loading peer insiders…
About this filer
CIK 0002006668
ROLE
Chief Financial Officer
PRIMARY
PMVP
COMPANIES
1
ACTIVE SINCE
Jan 2024
MARKETPEEL · /INSIDER/0002006668DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback